Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001709656 | SCV001936643 | benign | not provided | 2021-05-12 | criteria provided, single submitter | clinical testing | |
H3Africa Consortium | RCV001777170 | SCV002014633 | benign | not specified | 2020-10-28 | criteria provided, single submitter | research | While the frequency of the alternate allele in gnoMAD v2.0.2 is 0.375, its frequency in African populations is >5%. This suggests that previous classifications of this variant as pathogenic are in error. |
Breakthrough Genomics, |
RCV001709656 | SCV005272418 | benign | not provided | criteria provided, single submitter | not provided | ||
Central Research Laboratory, |
RCV000498386 | SCV000590817 | pathogenic | Congenital heart disease | 2017-01-07 | no assertion criteria provided | clinical testing | |
Reproductive Health Research and Development, |
RCV000498386 | SCV001142387 | benign | Congenital heart disease | 2020-01-06 | no assertion criteria provided | curation | NM_002052.3:c.*1256A>T in the gene GATA4 has an allele frequency of 0.376 in African subpopulation in the gnomAD database. 1936 homozygous occurrences are observed in the gnomAD database. This evidence suggests the variant to be classified as benign. ACMG/AMP criteria applied: BA1; BS2. |